Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Amenamevir

Generic Name: Amenamevir

Drug Type: Small Molecule

Chemical Formula: C_₂₄H_₂₆N_₄O_₅S

CAS Number: 841301-32-4

Unique Ingredient Identifier: 94X46KW4AE

Overview

Amenamevir has been used in trials studying the treatment of Herpes Zoster, Herpes Simplex, Herpes Genitalis, and Safety of Amenamevir.

Background

Amenamevir has been used in trials studying the treatment of Herpes Zoster, Herpes Simplex, Herpes Genitalis, and Safety of Amenamevir.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of Food

Phase 1

Completed

Posted: 2016/08/02

Sponsor:Astellas Pharma Euro...

ID:NCT02852876

Study to Evaluate the Safety and Pharmacokinetics of ASP2151 in Healthy Non-elderly and Elderly Subjects

Phase 1

Completed

Posted: 2016/06/10

Sponsor:Astellas Pharma Inc

ID:NCT02796118

Drug-Drug Interaction Study: ASP2151 and Midazolam

Phase 1

Completed

Posted: 2015/03/31

Sponsor:

Maruho Europe Limite...

ID:NCT02403635

Drug-Drug Interaction Study: ASP2151 and Bupropion

Phase 1

Completed

Posted: 2015/02/23

Sponsor:

Maruho Europe Limite...

ID:NCT02369172

Drug-Drug Interaction Study: ASP2151 and Montelukast

Phase 1

Completed

Posted: 2014/12/22

Sponsor:

Maruho Europe Limite...

ID:NCT02321748

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy